Chemours (CC) Up 7.5% Since Last Earnings Report: Can It Continue?
Chemours shares rose 7.5% post-earnings despite a $274 million Q2 2026 net loss missing estimates. The company forecasts net sales growth and adjusted EBITDA ranges for Q3 and full-year 2026.
Yahoo Finance · 2026-09-03 15:34 UTC